Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AGA Medical Wraps Up Septal Occluder Trial Enrollment For ASD Repair

This article was originally published in The Gray Sheet

Executive Summary

AGA Medical plans to submit initial data in early 1999 supporting a premarket approval application for its Amplatzer septal occluder for treatment of atrial septal defects. Over the next two to three months, the company expects to complete the control arm of the pivotal study, a prospective surgical cohort.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts